1. Home
  2. XBIO vs GBR Comparison

XBIO vs GBR Comparison

Compare XBIO & GBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XBIO
  • GBR
  • Stock Information
  • Founded
  • XBIO N/A
  • GBR 1978
  • Country
  • XBIO United States
  • GBR United States
  • Employees
  • XBIO N/A
  • GBR N/A
  • Industry
  • XBIO Biotechnology: Pharmaceutical Preparations
  • GBR Oil & Gas Production
  • Sector
  • XBIO Health Care
  • GBR Energy
  • Exchange
  • XBIO Nasdaq
  • GBR Nasdaq
  • Market Cap
  • XBIO 6.3M
  • GBR 6.1M
  • IPO Year
  • XBIO N/A
  • GBR N/A
  • Fundamental
  • Price
  • XBIO $4.06
  • GBR $1.12
  • Analyst Decision
  • XBIO Hold
  • GBR
  • Analyst Count
  • XBIO 1
  • GBR 0
  • Target Price
  • XBIO N/A
  • GBR N/A
  • AVG Volume (30 Days)
  • XBIO 22.9K
  • GBR 9.7K
  • Earning Date
  • XBIO 11-12-2024
  • GBR 11-13-2024
  • Dividend Yield
  • XBIO N/A
  • GBR N/A
  • EPS Growth
  • XBIO N/A
  • GBR N/A
  • EPS
  • XBIO N/A
  • GBR N/A
  • Revenue
  • XBIO $2,523,427.00
  • GBR $147,000.00
  • Revenue This Year
  • XBIO N/A
  • GBR N/A
  • Revenue Next Year
  • XBIO N/A
  • GBR N/A
  • P/E Ratio
  • XBIO N/A
  • GBR N/A
  • Revenue Growth
  • XBIO 7.15
  • GBR N/A
  • 52 Week Low
  • XBIO $2.78
  • GBR $0.95
  • 52 Week High
  • XBIO $5.20
  • GBR $1.82
  • Technical
  • Relative Strength Index (RSI)
  • XBIO 52.07
  • GBR 38.51
  • Support Level
  • XBIO $3.92
  • GBR $1.13
  • Resistance Level
  • XBIO $4.27
  • GBR $1.25
  • Average True Range (ATR)
  • XBIO 0.25
  • GBR 0.02
  • MACD
  • XBIO -0.04
  • GBR -0.00
  • Stochastic Oscillator
  • XBIO 38.45
  • GBR 0.00

About XBIO Xenetic Biosciences Inc.

Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing immune-oncology technologies addressing cancers. The company is also engaged in progressing XCART, a personalized CAR T platform technology. The Company's DNase platform is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which have been implicated in cancer progression and resistance to cancer treatments. The company also has oncology therapeutic investigational drug candidate XBIO-101 for the treatment of progestin-resistant endometrial cancer.

About GBR New Concept Energy Inc

New Concept Energy Inc is a United States-based company engaged in Real Estate Operations. It intends to continue to operate and or sell its West Virginia property. It provides advisory and management services for an independent West Virginia oil and gas company. The Company seeks to establish or acquire new business operations. It operates in one segment, which is real estate rental.

Share on Social Networks: